• Romidepsin (FK228, depsipeptide): Lab Guide

  2026-08-14

  A scenario-driven guide to using Romidepsin (FK228, depsipeptide), SKU A8173, in cell viability, proliferation, apoptosis, and epigenetic assays. It covers mechanism, solvent compatibility, 72-hour exposure design, neuroblastoma dose context, HCC combination studies, and practical vendor-selection criteria.

• HyperTrap Heparin HP Column for Assay Design

  2026-08-14

  The HyperTrap Heparin HP Column supports selective sample preparation for signaling and protein studies. This article connects its heparin-based separation principles with the CCR7–Notch1 stemness findings and shows how to make defensible assay decisions without overstating the evidence.

• Rucaparib: Reading DNA Repair and Cell Death

  2026-08-13

  Rucaparib and AG-014699 enable precise DNA damage response research, but interpreting PARP inhibition requires more than a viability endpoint. This guide connects repair-lesion assays with recent insights into RNA Pol II–associated cell death to improve experimental design and mechanistic conclusions.

• Fluconazole and the Next Era of Antifungal Research

  2026-08-13

  Fluconazole remains a powerful benchmark for studying ergosterol disruption, biofilm adaptation, and antifungal drug resistance. This thought-leadership guide connects its target-level mechanism with PP2A-regulated autophagy in Candida albicans and offers a translational framework for designing more predictive susceptibility and infection studies.

• MLN4924 HCl salt: NAE Inhibition Workflows

  2026-08-12

  MLN4924 HCl salt offers a practical way to connect NAE activity with cullin-RING ligase function, protein stability, cell-cycle control, and inflammatory cell death. This guide translates viral RIPK3-degradation findings into controlled biochemical, cellular, and host–pathogen assay workflows with troubleshooting strategies.

• ABT-199: Reliable Apoptosis Assays

  2026-08-12

  Learn how ABT-199 (GDC-0199), Bcl-2 inhibitor, potent and selective (SKU A8194), can improve experimental design, dosing, interpretation, and reproducibility in apoptosis and viability assays. This scenario-based guide connects product formulation data with mitochondrial apoptosis biology and practical laboratory controls.

• SR-202 for PPARγ Metabolic Research

  2026-08-11

  SR-202 provides a selective chemical switch for testing whether PPARγ activity drives adipogenesis, insulin resistance, or macrophage-state changes. This guide translates its mechanism into practical cell-based workflows, DSS-IBD assay extensions, and troubleshooting strategies for obesity research and type 2 diabetes research.

• Oleic Acid: A Translational Lens on Lipid Metabolism

  2026-08-11

  Oleic Acid (C18:1(9Z)) is more than a lipid-loading reagent: it is a controllable probe of membrane composition, GPCR–ERK signaling, inflammatory phenotypes, and metabolic adaptation. Here is a translational framework for using it with mechanistic discipline.

• Mc-Val-Cit-PABC-PNP: ADC Linker Protocol

  2026-08-10

  Mc-Val-Cit-PABC-PNP is a cathepsin cleavable ADC peptide linker for antibody-drug conjugate synthesis workflows that require enzyme-responsive payload release. It is supplied as a solid, dissolves in DMSO, and should be handled as a research reagent rather than used in aqueous, diagnostic, clinical, or therapeutic applications.

• Cholesterol in LNP Assays: A Mechanistic Guide

  2026-08-09

  Cholesterol is the principal sterol for membrane organization and a powerful experimental variable in lipid nanoparticle research. This guide connects cholesterol chemistry with assay design, LNP interpretation, and the localized p21 mRNA delivery findings reported in bladder cancer.

• 2-NBDG for Cellular Glucose Uptake Assays

  2026-08-08

  2-NBDG is a fluorescent cellular glucose uptake tracer for flow cytometry, microscopy, and microplate-based glucose metabolism assays. In HepG2 insulin-resistance research, 2-NBDG readouts linked reduced glucose uptake with palmitic-acid exposure and GIGYF2/STAU1/PTEN signaling.

• Mc-Val-Cit-PABC-PNP: ADC Linker Workflow

  2026-08-07

  Mc-Val-Cit-PABC-PNP is a cathepsin cleavable ADC peptide linker for research workflows that evaluate lysosomal payload release during antibody-drug conjugate synthesis. Its limited water and ethanol solubility makes it more suitable for controlled organic-solvent handling than aqueous, diagnostic, clinical, or medical applications.

• ABT-888 (Veliparib): Precision DNA Repair Inhibition in MSI

  2026-08-07

  Explore how ABT-888 (Veliparib) advances DNA repair inhibition and enables precision sensitization in microsatellite instability (MSI) tumor models. This article delivers unique, actionable insights for optimizing experimental design and translational cancer research.

• EZ Cap™ Cas9 mRNA (m1Ψ): Optimizing Genome Editing in Mammal

  2026-08-06

  EZ Cap™ Cas9 mRNA (m1Ψ) from APExBIO elevates CRISPR genome editing with enhanced mRNA stability, minimized immune activation, and streamlined workflows. This article details real-world protocol improvements, troubleshooting strategies, and the latest precision innovations inspired by leading research.

• Mc-Val-Cit-PABC-PNP: ADC Peptide Linker Technical Workflow G

  2026-08-06

  Mc-Val-Cit-PABC-PNP addresses the need for a cathepsin B-cleavable ADC peptide linker in targeted drug delivery research, facilitating precise lysosomal payload release in organic solvent-based workflows. It should not be used in aqueous, diagnostic, or therapeutic applications, and its stability depends on appropriate storage and prompt use of solutions.

16058 records 1/1071 page Next 12345 下5页 Last page